Primoceler
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m | 1.1m | 1.3m |
| % growth | 61 % | (7 %) | (19 %) | 19 % | (2 %) | 34 % | 20 % |
| EBITDA | <1m | <1m | (<1m) | (<1m) | (<1m) | (<1m) | - |
| % EBITDA margin | 57 % | 20 % | (84 %) | (70 %) | (112 %) | (55 %) | - |
| Profit | (<1m) | (<1m) | (1.2m) | (1.1m) | (1.3m) | (<1m) | - |
| % profit margin | (6 %) | (54 %) | (164 %) | (129 %) | (163 %) | (77 %) | - |
| R&D budget | 2.0m | 1.0m | <1m | <1m | - | - | - |
| R&D % of revenue | 213 % | 115 % | 100 % | 95 % | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Early VC | |
| Total Funding | - | ||
Related Content
Recent News about Primoceler
EditPrimoceler specializes in laser bonding technology, focusing on microelectronics and medical device industries. The company operates in the high-tech manufacturing sector, providing solutions that enable the creation of hermetically sealed microelectronic packages and medical devices without the need for heat or adhesives. This technology is particularly beneficial for applications requiring high precision and reliability, such as in aerospace, defense, and healthcare. Primoceler's business model revolves around selling its proprietary laser bonding equipment and offering specialized bonding services to its clients. Revenue is generated through equipment sales, service contracts, and consulting fees. The company serves a global market, catering to manufacturers and developers who require advanced bonding solutions for their high-performance products.
Keywords: laser bonding, microelectronics, medical devices, hermetic sealing, high-tech manufacturing, precision, reliability, aerospace, defense, healthcare.